Levofloxacin in pharma franchise in Meghalaya

Levofloxacin in PCD pharma franchise in Imphal

Levofloxacin in top pharma company in Coimbatore

Levofloxacin in pcd pharma supplier in Vijayawada

Levofloxacin in phama franchise company in India
Levofloxacin in phama distributor in Jodhpur

Home/Products /levofloxacin-500mg-infusion-infusion

About the Product

Description


Lexoziff IV Infusion contains Levofloxacin 500mg, a potent fluoroquinolone antibiotic. It is designed for intravenous administration to provide rapid and effective treatment for severe bacterial infections. Levofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for DNA replication, transcription, and repair. This broad-spectrum antibiotic is highly effective against a wide range of Gram-positive and Gram-negative bacteria, including both aerobic and anaerobic strains.

Lexoziff IV Infusion ensures efficient drug delivery in critically ill patients or when oral administration is not feasible. It is widely used in hospital settings for the management of serious infections.

May cause nausea, diarrhea, dizziness, or injection site reactions; rare cases include tendonitis or hypersensitivity.

Used for severe bacterial infections like pneumonia, urinary tract infections, skin infections, and sepsis.

Use under medical supervision. Complete the prescribed course and avoid use in pregnancy or children unless necessary.

Store below 25°C, away from light. Do not freeze.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levofloxacin 500mg Infusion in the PCD pharma franchise market?

Levofloxacin 500mg Infusion is a broad-spectrum antibiotic used in hospitals for moderate to severe bacterial infections, including respiratory tract infections, sepsis, urinary tract infections, and complicated skin infections. It is a strong hospital-care and anti-infective injectable segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this infusion in their product range?

Medical distributors and wholesalers can benefit from strong hospital demand in ICU, emergency, and inpatient care settings. It is widely used when oral antibiotics are not suitable, ensuring consistent institutional orders and high-value prescriptions.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for injectable and hospital-care formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this injectable antibiotic product?

Wholesalers and medical agencies benefit from hospital procurement, ICU demand, emergency usage, and high-value institutional sales when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Levofloxacin 500mg Infusion?

Medical distributors, stockists, wholesalers, hospital suppliers, and pharma professionals interested in this injectable antibiotic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.